Ustekinumab으로 성공적으로 치료한 뱀독에 의한 홍색피부건선 1예 = A case of Erythrodermic Psoriasis Induced by Snake Venom Successfully Treated with Ustekinumab

다국어 초록 (Multilingual Abstract)

Erythrodermic psoriasis (EP) is a severe form of psoriasis that can affect nearly entire body surface area. Aggravating factors such as infection, Koebner reaction and sudden withdrawal of systemic therapy can acutely arouse erythroderma in chronic psoriasis patients. In recent studies, ustekinumab has been shown to be effective against EP which has not responded to conventional treatments. A 65-year-old female with a 6-year history of psoriasis was admitted with generalized erythema and desquamation after taking snake venom as an alternative medicine. Considering clinical manifestations and histopathologic findings, she was diagnosed as EP. She was treated with systemic corticosteroid and cyclosporine, but the remaining lesion persisted and her itching, painful symptoms did not respond to cyclosporine treatment. Ustekinumab treatment was started, and after the first injection, the patient showed remarkable improvement of psoriatic lesions. Herein, we report a case of successful treatment with ustekinumab of erythrodermic psoriasis induced by snake venom.

참고문헌 (Reference)

1 Singh RK, "Erythrodermic psoriasis: pathophysiology and current treatment perspectives" 6 : 93-104, 2016

2 Pescitelli L, "Erythrodermic psoriasis treated with ustekinumab : an Italian multicenter retrospective analysis" 78 : 149-151, 2015

3 Tsai TF, "Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL)" 63 : 154-163, 2011

4 Viguier M, "Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study" 167 : 417-423, 2012

5 Boda F, "Effect of Vipera ammodytes ammodytes Snake Venom on the Human Cytokine Network" 10 : 259-, 2018

6 Hulmani M, "Clinico-etiological study of 30 erythroderma cases from tertiary center in South India" 5 : 25-29, 2014

7 Wang TS, "Clinical experience of ustekinumab in the treatment of erythrodermic psoriasis : a case series" 38 : 1096-1099, 2011

8 Wang TS, "Clinical experience of ustekinumab in the treatment of erythrodermic psoriasis : a case series" 38 : 1096-1099, 2011

9 Levin EC, "Biologic therapy in erythrodermic and pustular psoriasis" 13 : 342-354, 2014